Expression of Fas ligand in Langerhans' cell histiocytosis: A case report of a boy with multisystem involvement

American Journal of Hematology

Volumn 61, Issue 4, 1999, Pages 256-261

  Peng, Ching Tien ^a   Chow, Kuan Chih ^a   Chang, Wu Chung ^a   Tsai, Chang Hai ^a   Lin, Tze Yi ^a   Lin, Sheng Shing ^a   Chiu, Chan Fang ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CT; Fas ligand; Histiocytosis; Immunocytochemistry; Langerhans' cell; MRI

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD68 ANTIGEN; CD86 ANTIGEN; FAS LIGAND; INTERLEUKIN 2 RECEPTOR; LYSOZYME; PROTEIN S 100;

ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CELL LINEAGE; CEREBELLUM TUMOR; COMPUTER ASSISTED TOMOGRAPHY; HEPATOMEGALY; HISTIOCYTOSIS X; HUMAN; ILIAC BONE; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIB;

ANTIGENS, CD; ANTIGENS, CD95; CHILD, PRESCHOOL; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032819633     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199908)61:4<256::AID-AJH6>3.0.CO;2-3     Document Type: Article

References (35)

1. Luken JN. Langerhans' cell histiocylosis. In Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, eds. Wintrobe's Clinical Hematology, Volume 2. Philadelphia: Lea & Bebiger, 1993.
2. Beckstead JH, Wood GS, Turner RR. Histiocytosis X cells and Langerhans cells: enzyme histochemical and immunologic similarities. Hum Pathol 1984;15:826.
3. Fithian E, Kung P, Goldstein G, Rubenfeld M, Fenoglio C, Edelson R. Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci USA 1981;78:2541.
4. Robb IA, Jimenez CL, Carpenter BF. Birbeck granules or Birbeck junctions? Intercellular "zipperlike" lattice junctions in eosinophilic granuloma of bone. Ultrastruct Pathol 1992;16:423.
5. Takahashi K, Asagoe K, Zaishun J, et al. Heterogeneity of dendritic cells in human superficial lymph node: in vitro maturation of immature dendritic cells into mature or activated interdigitating reticulum cells. Am J Pathol 1998;153:745.
6. Strobl H, Scheinecker C, Riedl E, et al. Identification of CD68+lin-peripheral blood cells with dendritic precursor characteristics. J Immunol 1998;161:740.
7. Luft T, Pang KC, Thomas E, et al. A serum-free culture model for studying the differentiation of human dendritic cells from adult CD34+ progenitor cells. Exp Hematol 1998;26:489.
8. Herbst B, Kohler G, Mackensen A, Veelken H, Lindemann A.GMCSF promotes differentiation of a precursor cell of monocytes and Langerhans-type dendritic cells from CD34+ haemopoietic progenitor cells. Br J Haematol 1998;101:231.
9. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, Hermine O. Transforming growth factor beta 1, in the presence of granulocyte/ macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998;187:961.
10. Malone M. The histiocytoses of childhood. Histopathology 1991;19: 105.
11. Cline MJ. Histiocytes and histiocytosis. Blood 1994;84:2840.
12. Ruco LP, Remotti D, Monardo F, et al. Letterer-Siwe disease: immunohistochemical evidence for a proliferative disorder involving immature cells of Langerhans lineage. Virchows Arch A Pathol Anat Histopathol 1988;413:239.
13. Nagaoka S, Maruyama R, Koike M, et al. Cytology of Langerhans' cell histiocytosis in effusions. Acta Cytol 1996;40:563.
14. Wang WS, Liu JH, Yang CF, Yang AH, Chen PM. Langerhans' cell histiocytosis (histiocytosis-X) in a woman with typical ultrastructure of Birbeck's granule: a case report. Chin Med J (Taipei) 1996;58:281.
15. Angeli SI, Luxford WM, Lo WWM. Magnetic resonance imaging in the evaluation of Langerhans' cell histiocytosis of the temporal bone: case report. Otolaryngol Head Neck Surg 1996;114:120.
16. Bergmann M, Yuan Y, Palm KV, Rohkamm R. Solitary Langerhans' cell histiocytosis lesion of the parieto-occipital lobe: a case report and review of the literature. Clin Neurol Neurosurg 1997;99:50.
17. Favara BE. Langerhans' cell histiocytosis pathobiology and pathogenesis. Semin Oncol 1991;18:3.
18. Arenzana-Seisdedos F, Barbey S, Virelizier JL, Kornprobst M, Nezelof C. Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture. J Clin Invest 1986;77:326.
19. Lader CS, Flanagan AM. Prostaglandin E2, interleukin 1 alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology 1998;139:3157.
20. Rosenfield NS, Abrahams J, Komp D. Brain MR in patients with Langerhans cell histiocytosis: findings and enhancement with Gd-DTPA. Pediatr Radiol 1990;20:433.
21. Chang YT, Liu HN, Chow KC, Chen KY, Wong CK. Detection of Epstein-Barr virus in primary cutaneous amyloidosis. Br J Dermatol 1997;136:823.
22. Chow KC, Nacilla JQ, Witzig TE, Li CY. Is persistent polyclonal B lymphocytosis caused by Epstein-Barr virus? - A study with polymerase chain reaction and in situ hybridization. Am J Hematol 1992;41: 270.
23. Kikuchi M. Lymphadennitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes. Acta Hematol Jpn 1972;35:379-380.
24. Emile J, Fraitag S, Leborgne M, Prost YD, Brousse N. Langerhans' cell histiocytosis cells are activated Langerhans' cells. J Pathol 1994; 174:71.
25. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994;343:767.
26. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med 1994;331:154.
27. Yu RC, Alaibac M, Chu AC. Functional defect in cells involved in Langerhans cell histiocytosis. Arch Dermatol Res 1995;287:627.
28. Hosmalin A, McIlroy D, Autran B, et al. Imbalanced "memory" T lymphocyte subsets and analysis of dendritic cell precursors in the peripheral blood of adult patients with Langerhans cell histiocytosis. Clin Exp Rheumatol 1997;15:649.
29. Geissmann F, Emile JF, Andry P, et al. Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome. J Pathol 1997;181:301.
30. Schultz C, Klouche M, Friedrichsdorf S, Richter N, Kroehnert B, Bucsky P. Langerhans cell histiocytosis in children: does soluble interleukin-2-receptor correlate with both disease extent and activity? Med Pediatr Oncol 1998;31:61.
31. Bove KE, Hurtubise P, Wong KY. Thymus in untreated systemic histiocytosis X. Pediatr Pathol 1985;4:99.
32. Kawakami A, Eguchi K, Matsuoka N, et al. Fas and Fas ligand interaction is necessary for human osteoblast apoptosis. J Bone Miner Res 1997;12:1637.
33. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res 1998;13:793.
34. Villunger A, Egle A, Marschitz I, et al. Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. Blood 1997;90:12.
35. Bataille R, Chappard D, Klein B. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. Int J Clin Lab Res 1992;21:283.